Swissmedic approves Pfizer-BioNTech booster shots from the age of 16

Swiss drugs regulator Swissmedic said on Tuesday it approved the extension of a booster dose of Pfizer-BioNTech's COVID-19 vaccine to everyone aged 16 years and over.

"This clears the way for wider use of the booster vaccination. High-risk individuals can still obtain a booster dose from age 12," Swissmedic said in a statement.

 

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)